- Lung
- Breast
- Prostate
- Pancreas
- Renal
- Spleen
- Thoracic Aneurysms
- Abdominal Aneurysms
- Ovary
- Liver
- Adrenal
- BI-RADS (Breast)
- PI-RADS (Prostate)
- TI-RADS (Thyroid)
- LI-RADS (Liver)
Incidental Findings & Lung Cancer Screening Management Made Powerfully Simple
Incidental Findings are discovered in approximately 31% of radiology reports, yet proper communication and follow-up occur only one out of every three times. We can change that! Utilizing advanced artificial intelligence, Thynk Health automates and simplifies the tracking and management of incidental findings for:
The Case for Incidental Findings Management
As imaging technology continues to advance, anomalies are increasingly more detectable, making incidental findings more commonplace. However, proper communication and follow-up of incidental findings occur only about 30% of occurrences. With early detection being one of the most effective tools to beat cancer, proper management of incidental findings has significant implications for patient care and risk mitigation for healthcare systems.
WHY CLIENTS PREFER THYNK HEALTH TECHNOLOGY SOLUTIONS
- Patients Lives - Our focus on early identification of cancer, shifting identification from Stage 3 & 4 to Stage 1 & 2, means more lives saved.
- Quality Assurance - Mitigate risks with automated communications and management of incidental findings, which experts currently estimate compliance to range from 29% to 77%.
- Accurate - Thynk Health’s cutting-edge artificial intelligence and deep learning technology lead the industry in accuracy
- Automated - Workflow becomes powerfully simple with advanced automation requiring fewer of your resources
- Easy - Deep learning algorithms familiarize with your reporting style and operate within existing workflow and systems
- Powerful - Actionable intelligence powers your cancer screening and incidental findings management program
- Secure - Clients can trust our solution is developed (and serviced) in the USA, we never outsource or offshore anything, especially sensitive healthcare data
- Configurable - Built with your unique needs and software requirements in mind
Empower your cancer screening program with the most advanced and accurate technology available.
A Powerful, Automated, and Scalable Cancer Screening Solution
Reduce lung cancer deaths by increasing early detection with a total lung cancer screening solution that identifies and screens more at-risk patients, detects lung cancer earlier, and ensures patients do not slip through the cracks of complex screening and care delivery programs.
- Identify more at-risk patients
- Automate communications
- Submit to ACR with 1-click
- Engage with providers to improve screening
- Track and retain patients
- Actionable insights and reports
“One of the great things that Thynk Health has provided us has been monthly feedback. Having objective feedback that tells us what’s working and what’s not working has been key to us making decisions not just at a yearly level, but at a monthly level. Each month we get on the phone, they come on site, and look at our data critically, constantly looking for opportunities. Without that type of data analysis you don’t really know what you’re doing well and what needs to change. In order to implement the lung cancer screening programs the quickest, you almost need to be able to make those decisions on a monthly basis.”
Dr. Robert Headrick
Cardiothoracic Surgeon at Regional Hospital
The Thynk Health platform optimizes data-driven workflows and provides operational and clinical analytics for lung cancer screening programs and other quality initiatives.